
|Videos|November 4, 2021
Targeted Therapies Are Impacting the Treatment of NETs
Nicole Ross, MSN, CRNP, AOCNP, nurse practitioner for the department of hematology/oncology at Fox Chase Cancer Center, discusses how targeted therapies are impacting the treatment of NETs.
Advertisement
In a Pharmacy Times® interview, Nicole Ross, MSN, CRNP, AOCNP, nurse practitioner for the department of hematology/oncology at Fox Chase Cancer Center, about her presentation on neuroendocrine tumor (NETs) management in large cancer centers at the NANETS 2021 Conference.
She discussed how targeted therapies are impacting the treatment of NETs.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Milestone Oral Therapy for Adults With Thalassemia Anemia
2
Reimagining Pharmacy: A Call to Action for Pharmacy Professionals
3
Lowering Blood Glucose in Prediabetes May Prevent Heart Attacks and Heart Failure
4
FDA Approves Narsoplimab-wuug for Transplant-Associated Thrombotic Microangiopathy
5









































































































































































































